Disruption of hypoxia-inducible fatty acid binding protein 7 induces beige fat-like differentiation and thermogenesis in breast cancer cells.
Breast cancer
FLIM
Fatty acid
Hypoxia
Modification of radiation sensitivity
Thermogenesis
UCP1
Journal
Cancer & metabolism
ISSN: 2049-3002
Titre abrégé: Cancer Metab
Pays: England
ID NLM: 101607582
Informations de publication
Date de publication:
2020
2020
Historique:
received:
23
02
2019
accepted:
18
05
2020
entrez:
11
7
2020
pubmed:
11
7
2020
medline:
11
7
2020
Statut:
epublish
Résumé
Humans produce heat through non-shivering thermogenesis, a metabolic process that occurs in inducible beige adipocytes expressing uncoupling protein 1 (UCP1). UCP1 dissipates the proton gradient of the mitochondrial inner membrane and converts that energy into heat. It is unclear whether cancer cells can exhibit autonomous thermogenesis. Previously, we found that the knockdown of hypoxia-inducible fatty acid binding protein 7 (FABP7) increased reactive oxygen species (ROS) in breast cancer cells. ROS are known to induce beige adipocyte differentiation. We investigated the association of tumor hypoxia, FABP7, and UCP1 across breast cancer patients using METABRIC and TCGA data sets. Furthermore, using a breast cancer cell line, HCC1806, we tested the effect of FABP7 knockdown on cellular physiology including thermogenesis. We found a strong mutual exclusivity of FABP7 and UCP1 expression both in METABRIC and in TCGA, indicating major metabolic phenotypic differences. FABP7 was preferentially distributed in poorly differentiated-, estrogen receptor (ER) negative tumors. In contrast, UCP1 was highly expressed in normal ducts and well-differentiated-, ER positive-, less hypoxic tumors. In the cell line-based experiments, UCP1 and its transcriptional regulators were upregulated upon FABP7 knockdown. UCP1 was induced in about 20% of cancer cells, and the effect was increased further in hypoxia. UCP1 depolarized mitochondrial membranes at the site of expression. UCP1 induction was associated with the increase in proton leak, glycolysis, and maximal respiration, mimicking the typical energy profile of beige adipocytes. Most importantly, UCP1 induction elevated cancer cell temperature associated with increased vulnerability to hypoxia and γ-irradiation. We demonstrated that breast cancer cells can undergo thermogenesis through UCP1 induction. Disrupting FABP7-mediated fatty acid metabolism can unlock UCP1-mediated thermogenesis, potentially making it possible to develop therapies to target thermogenesis. Further study would be warranted to investigate the effect of rise in temperature of cancer cells on patients' outcomes and the relationship to other metabolic pathways.
Sections du résumé
BACKGROUND
BACKGROUND
Humans produce heat through non-shivering thermogenesis, a metabolic process that occurs in inducible beige adipocytes expressing uncoupling protein 1 (UCP1). UCP1 dissipates the proton gradient of the mitochondrial inner membrane and converts that energy into heat. It is unclear whether cancer cells can exhibit autonomous thermogenesis. Previously, we found that the knockdown of hypoxia-inducible fatty acid binding protein 7 (FABP7) increased reactive oxygen species (ROS) in breast cancer cells. ROS are known to induce beige adipocyte differentiation.
METHODS
METHODS
We investigated the association of tumor hypoxia, FABP7, and UCP1 across breast cancer patients using METABRIC and TCGA data sets. Furthermore, using a breast cancer cell line, HCC1806, we tested the effect of FABP7 knockdown on cellular physiology including thermogenesis.
RESULTS
RESULTS
We found a strong mutual exclusivity of FABP7 and UCP1 expression both in METABRIC and in TCGA, indicating major metabolic phenotypic differences. FABP7 was preferentially distributed in poorly differentiated-, estrogen receptor (ER) negative tumors. In contrast, UCP1 was highly expressed in normal ducts and well-differentiated-, ER positive-, less hypoxic tumors. In the cell line-based experiments, UCP1 and its transcriptional regulators were upregulated upon FABP7 knockdown. UCP1 was induced in about 20% of cancer cells, and the effect was increased further in hypoxia. UCP1 depolarized mitochondrial membranes at the site of expression. UCP1 induction was associated with the increase in proton leak, glycolysis, and maximal respiration, mimicking the typical energy profile of beige adipocytes. Most importantly, UCP1 induction elevated cancer cell temperature associated with increased vulnerability to hypoxia and γ-irradiation.
CONCLUSIONS
CONCLUSIONS
We demonstrated that breast cancer cells can undergo thermogenesis through UCP1 induction. Disrupting FABP7-mediated fatty acid metabolism can unlock UCP1-mediated thermogenesis, potentially making it possible to develop therapies to target thermogenesis. Further study would be warranted to investigate the effect of rise in temperature of cancer cells on patients' outcomes and the relationship to other metabolic pathways.
Identifiants
pubmed: 32647572
doi: 10.1186/s40170-020-00219-4
pii: 219
pmc: PMC7336487
doi:
Types de publication
Journal Article
Langues
eng
Pagination
13Commentaires et corrections
Type : ErratumIn
Informations de copyright
© The Author(s) 2020.
Déclaration de conflit d'intérêts
Competing interestsThe authors declare that they have no competing interests.
Références
J Biol Chem. 2017 Oct 13;292(41):16810-16816
pubmed: 28842500
Cell. 2012 Jul 20;150(2):366-76
pubmed: 22796012
Nature. 2012 Oct 4;490(7418):61-70
pubmed: 23000897
Immunity. 2019 Jan 15;50(1):137-151.e6
pubmed: 30650373
Stem Cells. 2012 Jul;30(7):1532-43
pubmed: 22581784
Nat Rev Immunol. 2015 Jun;15(6):335-49
pubmed: 25976513
J Invest Dermatol. 2008 Aug;128(8):1894-900
pubmed: 18305572
Trends Biochem Sci. 2010 May;35(5):298-307
pubmed: 20006514
J Biol Chem. 2001 Dec 14;276(50):47291-5
pubmed: 11572862
Anal Chem. 2016 Nov 1;88(21):10566-10572
pubmed: 27696826
Nature. 2016 Apr 7;532(7597):112-6
pubmed: 27027295
Prog Lipid Res. 2013 Oct;52(4):562-70
pubmed: 23981365
Nat Rev Mol Cell Biol. 2005 Mar;6(3):248-61
pubmed: 15738989
Can Med Assoc J. 1956 Sep 15;75(6):486-8
pubmed: 13364771
J Pharmacol Exp Ther. 1998 Oct;287(1):157-66
pubmed: 9765335
Br J Cancer. 2010 Jan 19;102(2):428-35
pubmed: 20087356
J Biol Chem. 2012 Jan 27;287(5):3415-24
pubmed: 22170058
Sci Rep. 2018 Apr 27;8(1):6672
pubmed: 29704006
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Int J Cancer. 2019 Aug 15;145(4):1138-1147
pubmed: 30737786
Cell Metab. 2010 Apr 7;11(4):268-72
pubmed: 20374959
Can Med Assoc J. 1963 Jan 12;88(2):68-70
pubmed: 20327365
Nature. 2007 Jun 21;447(7147):959-65
pubmed: 17554340
Mol Cell Biol. 2004 Apr;24(7):3057-67
pubmed: 15024092
Trends Endocrinol Metab. 2017 Jan;28(1):19-31
pubmed: 27692461
Biochimie. 2017 Mar;134:86-92
pubmed: 27693079
Ann N Y Acad Sci. 1980;335:383-415
pubmed: 6931533
Trends Endocrinol Metab. 2015 Nov;26(11):589-592
pubmed: 26439976
Cell Metab. 2015 Oct 6;22(4):546-59
pubmed: 26445512
Cytometry. 1997 Jan 1;27(1):1-20
pubmed: 9000580
Cell Rep. 2014 Oct 9;9(1):349-365
pubmed: 25263561
Cell Metab. 2018 Jun 05;27(6):1348-1355.e4
pubmed: 29805098
Br J Cancer. 2020 Jan;122(2):245-257
pubmed: 31819188
Nat Protoc. 2006;1(5):2315-9
pubmed: 17406473
Clin Cancer Res. 2011 Apr 15;17(8):2159-69
pubmed: 21355075
Cancer Biol Med. 2017 Nov;14(4):396-404
pubmed: 29372106
J Pathol. 2012 Nov;228(3):310-21
pubmed: 22322885
Breast Cancer Res Treat. 2012 Jul;134(2):519-29
pubmed: 22562177
Bioorg Med Chem Lett. 2007 Jun 15;17(12):3511-5
pubmed: 17502136
Nat Protoc. 2019 May;14(5):1377-1400
pubmed: 30971781
Dis Model Mech. 2014 Jan;7(1):129-41
pubmed: 24159189
Cell Metab. 2010 Apr 7;11(4):248-52
pubmed: 20374955
Nature. 2012 Apr 18;486(7403):346-52
pubmed: 22522925
Mol Cancer Res. 2016 Jan;14(1):78-92
pubmed: 26464213
Breast Cancer Res Treat. 2010 May;121(1):41-51
pubmed: 19590950
N Engl J Med. 2009 Apr 9;360(15):1518-25
pubmed: 19357407